These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 1582974

  • 1. Cytokine network in human multiple myeloma.
    Klein B, Bataille R.
    Hematol Oncol Clin North Am; 1992 Apr; 6(2):273-84. PubMed ID: 1582974
    [Abstract] [Full Text] [Related]

  • 2. [Cytokines and lymphoplasmocytic proliferations: essential role of interleukin 6].
    Bataille R, Klein B.
    Rev Prat; 1993 Feb 01; 43(3):275-8. PubMed ID: 8502954
    [Abstract] [Full Text] [Related]

  • 3. Interleukin-6 is the central tumor growth factor in vitro and in vivo in multiple myeloma.
    Klein B, Zhang XG, Jourdan M, Boiron JM, Portier M, Lu ZY, Wijdenes J, Brochier J, Bataille R.
    Eur Cytokine Netw; 1990 Feb 01; 1(4):193-201. PubMed ID: 2104241
    [Abstract] [Full Text] [Related]

  • 4. IFN-alpha induces autocrine production of IL-6 in myeloma cell lines.
    Jourdan M, Zhang XG, Portier M, Boiron JM, Bataille R, Klein B.
    J Immunol; 1991 Dec 15; 147(12):4402-7. PubMed ID: 1753108
    [Abstract] [Full Text] [Related]

  • 5. A review of the cytokine network in multiple myeloma: diagnostic, prognostic, and therapeutic implications.
    Lauta VM.
    Cancer; 2003 May 15; 97(10):2440-52. PubMed ID: 12733143
    [Abstract] [Full Text] [Related]

  • 6. Cooperation between heparin-binding EGF-like growth factor and interleukin-6 in promoting the growth of human myeloma cells.
    Wang YD, De Vos J, Jourdan M, Couderc G, Lu ZY, Rossi JF, Klein B.
    Oncogene; 2002 Apr 11; 21(16):2584-92. PubMed ID: 11971193
    [Abstract] [Full Text] [Related]

  • 7. Disruption by interferon-alpha of an autocrine interleukin-6 growth loop in IL-6-dependent U266 myeloma cells by homologous and heterologous down-regulation of the IL-6 receptor alpha- and beta-chains.
    Schwabe M, Brini AT, Bosco MC, Rubboli F, Egawa M, Zhao J, Princler GL, Kung HF.
    J Clin Invest; 1994 Dec 11; 94(6):2317-25. PubMed ID: 7989587
    [Abstract] [Full Text] [Related]

  • 8. IFN-alpha is a survival factor for human myeloma cells and reduces dexamethasone-induced apoptosis.
    Ferlin-Bezombes M, Jourdan M, Liautard J, Brochier J, Rossi JF, Klein B.
    J Immunol; 1998 Sep 15; 161(6):2692-9. PubMed ID: 9743325
    [Abstract] [Full Text] [Related]

  • 9. Regulation of Bcl-2-family proteins in myeloma cells by three myeloma survival factors: interleukin-6, interferon-alpha and insulin-like growth factor 1.
    Jourdan M, De Vos J, Mechti N, Klein B.
    Cell Death Differ; 2000 Dec 15; 7(12):1244-52. PubMed ID: 11175262
    [Abstract] [Full Text] [Related]

  • 10. Transcription of genes encoding granulocyte-macrophage colony-stimulating factor, interleukin 3, and interleukin 6 receptors and lack of proliferative response to exogenous cytokines in nonhematopoietic human malignant cell lines.
    Guillaume T, Sekhavat M, Rubinstein DB, Hamdan O, Symann ML.
    Cancer Res; 1993 Jul 01; 53(13):3139-44. PubMed ID: 8319222
    [Abstract] [Full Text] [Related]

  • 11. [The cytokine network in multiple myeloma].
    Bacovský J, Scudla V.
    Vnitr Lek; 1994 Aug 01; 40(8):517-20. PubMed ID: 7941439
    [Abstract] [Full Text] [Related]

  • 12. Tumor necrosis factor is a survival and proliferation factor for human myeloma cells.
    Jourdan M, Tarte K, Legouffe E, Brochier J, Rossi JF, Klein B.
    Eur Cytokine Netw; 1999 Mar 01; 10(1):65-70. PubMed ID: 10210775
    [Abstract] [Full Text] [Related]

  • 13. Expression and production of interleukin 10 in human myeloma cell lines.
    Otsuki T, Yamada O, Yata K, Sakaguchi H, Kurebayashi J, Yawata Y, Ueki A.
    Br J Haematol; 2000 Dec 01; 111(3):835-42. PubMed ID: 11122145
    [Abstract] [Full Text] [Related]

  • 14. Growth regulatory pathways in myeloma. Evidence for autocrine oncostatin M expression.
    Westendorf JJ, Jelinek DF.
    J Immunol; 1996 Oct 01; 157(7):3081-8. PubMed ID: 8816418
    [Abstract] [Full Text] [Related]

  • 15. Role of INTERLEUKIN-6 in the pathogenesis of multiple myeloma.
    Gadó K, Domján G, Hegyesi H, Falus A.
    Cell Biol Int; 2000 Oct 01; 24(4):195-209. PubMed ID: 10816321
    [Abstract] [Full Text] [Related]

  • 16. IL-1, IL-4, and IFN-gamma differentially regulate cytokine production and cell surface molecule expression in cultured human thymic epithelial cells.
    Galy AH, Spits H.
    J Immunol; 1991 Dec 01; 147(11):3823-30. PubMed ID: 1719090
    [Abstract] [Full Text] [Related]

  • 17. Delineation of the roles of paracrine and autocrine interleukin-6 (IL-6) in myeloma cell lines in survival versus cell cycle. A possible model for the cooperation of myeloma cell growth factors.
    Jourdan M, Mahtouk K, Veyrune JL, Couderc G, Fiol G, Redal N, Duperray C, De Vos J, Klein B.
    Eur Cytokine Netw; 2005 Dec 01; 16(1):57-64. PubMed ID: 15809207
    [Abstract] [Full Text] [Related]

  • 18. The role of monocyte-derived hemopoietic growth factors in the regulation of myeloproliferation in juvenile chronic myelogenous leukemia.
    Emanuel PD, Bates LJ, Zhu SW, Castleberry RP, Gualtieri RJ, Zuckerman KS.
    Exp Hematol; 1991 Nov 01; 19(10):1017-24. PubMed ID: 1915702
    [Abstract] [Full Text] [Related]

  • 19. Establishment and characterization of three myeloma cell lines that demonstrate variable cytokine responses and abilities to produce autocrine interleukin-6.
    Westendorf JJ, Ahmann GJ, Greipp PR, Witzig TE, Lust JA, Jelinek DF.
    Leukemia; 1996 May 01; 10(5):866-76. PubMed ID: 8656685
    [Abstract] [Full Text] [Related]

  • 20. MLN120B, a novel IkappaB kinase beta inhibitor, blocks multiple myeloma cell growth in vitro and in vivo.
    Hideshima T, Neri P, Tassone P, Yasui H, Ishitsuka K, Raje N, Chauhan D, Podar K, Mitsiades C, Dang L, Munshi N, Richardson P, Schenkein D, Anderson KC.
    Clin Cancer Res; 2006 Oct 01; 12(19):5887-94. PubMed ID: 17020997
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.